What is the ESG rating for HAE?

Haemonetics Corporation has the following ESG ratings: ESG Enterprise Score: 19.6 (E:N/A S:N/A G:N/A).

What are the key financial metrics for HAE?

Key financial metrics for Haemonetics Corporation include: Market Cap: $18.58 billion, Current Price: $445.69, Dividend Yield: 2.64%.

Search for stocks by symbol or company name. Use arrow keys to navigate suggestions.

Empowering retail investors to invest responsibly for their future while making a positive social impact.

Join our newsletter to get updates on impact investing opportunities.

Email address for newsletter subscription

*I agree to receive emails and accept the privacy policy

Search for stocks by symbol or company name. Use arrow keys to navigate suggestions.

Empowering retail investors to invest responsibly for their future while making a positive social impact.

Join our newsletter to get updates on impact investing opportunities.

Email address for newsletter subscription

*I agree to receive emails and accept the privacy policy

Haemonetics Corporation (HAE) Stock Analysis & ESG Ratings | The Impact Investor

HAE

$445.69Quote delayed; real-time unavailable.

Haemonetics Corporation

Loading HAE text...

Current Price

Loading HAE text...

Today's Change

Loading HAE text...

Volume

22.87

P/E Ratio

Haemonetics Corporation

Current Price

Loading HAE text...

Market Cap

Loading HAE text...

No ESG ratings available

Loading HAE card...

Loading 5 stocks ticker...

Loading HAE card...